scholarly journals In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide

2007 ◽  
Vol 13 (10) ◽  
pp. 1253-1258 ◽  
Author(s):  
Martina A McAteer ◽  
Nicola R Sibson ◽  
Constantin von zur Muhlen ◽  
Jurgen E Schneider ◽  
Andrew S Lowe ◽  
...  

Nanoscale ◽  
2018 ◽  
Vol 10 (38) ◽  
pp. 18398-18406 ◽  
Author(s):  
Ruixue Wei ◽  
Tiantian Zhou ◽  
Chengjie Sun ◽  
Hongyu Lin ◽  
Lijiao Yang ◽  
...  

Iron oxide twin nanoplates with high T2 relaxivity for in vivo contrast-enhanced magnetic resonance imaging and tumor imaging were reported.



2008 ◽  
Vol 20 (9) ◽  
pp. 1671-1678 ◽  
Author(s):  
Xiangyang Shi ◽  
Su He Wang ◽  
Scott D. Swanson ◽  
Song Ge ◽  
Zhengyi Cao ◽  
...  


Author(s):  
Martina A. McAteer ◽  
Constantin von Zur Muhlen ◽  
Daniel C. Anthony ◽  
Nicola R. Sibson ◽  
Robin P. Choudhury


2011 ◽  
Vol 111 (2) ◽  
pp. 253-280 ◽  
Author(s):  
Morteza Mahmoudi ◽  
Hossein Hosseinkhani ◽  
Mohsen Hosseinkhani ◽  
Sebastien Boutry ◽  
Abdolreza Simchi ◽  
...  


2015 ◽  
Vol 2015 ◽  
pp. 1-10 ◽  
Author(s):  
Fei Yan ◽  
Wei Yang ◽  
Xiang Li ◽  
Hongmei Liu ◽  
Xiang Nan ◽  
...  

The goal of this study is to investigate the feasibility of using CD81- (Cluster of Differentiation 81 protein-) targeted microparticles of iron oxide (CD81-MPIO) for magnetic resonance imaging (MRI) of the murine atherosclerosis. CD81-MPIO and IgG- (Immunoglobulin G-) MPIO were prepared by covalently conjugating, respectively, with anti-CD81 monoclonal and IgG antibodies to the surface of the tosyl activated MPIO. The relevant binding capability of the MPIO was examined by incubating them with murine bEnd.3 cells stimulated with phenazine methosulfate (PMS) and its effect in shortening T2 relaxation time was also examined. MRI in apolipoprotein E-deficient mice was studied in vivo. Our results show that CD81-MPIO, but not IgG-MPIO, can bind to the PMS-stimulated bEnd.3 cells. The T2 relaxation time was significantly shortened for stimulated bEnd.3 cells when compared with IgG-MPIO. In vivo MRI in apolipoprotein E-deficient mice showed highly conspicuous areas of low signal after CD81-MPIO injection. Quantitative analysis of the area of CD81-MPIO contrast effects showed 8.96- and 6.98-fold increase in comparison with IgG-MPIO or plain MPIO, respectively (P<0.01). Histological assay confirmed the expression of CD81 and CD81-MPIO binding onto atherosclerotic lesions. In conclusion, CD81-MPIO allows molecular assessment of murine atherosclerotic lesions by magnetic resonance imaging.



Sign in / Sign up

Export Citation Format

Share Document